Home
About
Overview
Sharing Data
ORCID
Help
History (86)
Desoximetasone
Cole, Naida
Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: a trial of the California, Chicago, and Princess Margaret Hospital phase II consortia.
Short (= 1 mm) positive surgical margin and risk of biochemical recurrence after radical prostatectomy.
High-throughput characterization of genetic effects on DNA-protein binding and gene transcription.
See All 86 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
High-throughput characterization of genetic effects on DNA-protein binding and gene transcription.
High-throughput characterization of genetic effects on DNA-protein binding and gene transcription. Genome Res. 2018 11; 28(11):1701-1708.
View in:
PubMed
subject areas
Alleles
Cell Line
High-Throughput Screening Assays
Humans
NF-kappa B p50 Subunit
Polymorphism, Single Nucleotide
Protein Binding
Regulatory Sequences, Nucleic Acid
Transcriptional Activation
authors with profiles
Francesca Luca